NEURONES: Organic growth up 5.1% in 1st half 2018
August 01 2018 - 10:40AM
PRESS INFORMATION
Nanterre, August 1, 2018 (after trading)
Heading: Revenues H1 2018
Organic growth up
5.1% in 1st half 2018
| (in millions of euros) |
H1 2017
restated IFRS15 (*) |
H1 2018
IFRS15 (*) |
growth |
of which organic |
|
Revenues |
239.2 |
243.1 |
+ 1.6% |
+ 5.1% |
Achievements
With constant structures and
similar accounting method (IFRS15), organic growth is up 5.1% for
the first six months of 2018.
The operating profit for the
half-year is 8.5% of revenues (**), compared with 8.6% for the
first half of 2017.
In comparison with the 2017
reference document available in the Finance section on the Neurones
website (www.neurones.net, "Finance" page), there were no
significant changes in the financial situation.
Outlook
With constant structures, NEURONES
forecasts the following for 2018:
- close to €490m in revenues
(IFRS15*),
- an operating profit of
approximately 9% of revenues.
(*) Application of
IFRS15 reduced the group's revenues by around €9 million in 2017
and 2018, naturally with no impact on operating profit.
(**) Unaudited and after inclusion
of 0.3% expenses related to bonus shares.
About
NEURONES
With over 5,100 employees, the
NEURONES group specializes in Consulting (Management, Organization
and Digital) and IT Services (Infrastructures and Applications). It
supports its clients in their digital transformation and
information system outsourcing projects.
Euronext Paris (compartment B -
NRO) - Enternext Tech 40 - SRD medium values
www.neurones.net
Press Relations:
Florence Gillier Communication
Sabine GROSDIDIER
+33 1 41 18 85 55
sabineg@fgcom.fr |
NEURONES
Matthieu VAUTIER
+33 1 41 37 41 37
rp@neurones.net |
Investor Relations:
NEURONES
Paul-César BONNEL
+33 1 41 37 41 37
investisseurs@neurones.net |
NEURONES-H1-2018-revenues
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: NEURONES via Globenewswire
Neurones (EU:NRO)
Historical Stock Chart
From Feb 2025 to Mar 2025
Neurones (EU:NRO)
Historical Stock Chart
From Mar 2024 to Mar 2025
